Effects of breed and zeranol implantation on serum insulin, somatomedin-like activity and fibroblast proliferative activity.
Twenty-eight Suffolk-sired (Sx) and 28 Finnsheep-sired (Fx) lambs were implanted with either 0 or 12 mg zeranol. Zeranol significantly increased average daily gain over that of controls. Serum taken at biweekly intervals for 6 weeks was assayed for insulin, somatomedin-like activity (Sm) and fibroblast proliferative activity (FPA). Insulin appeared to increase with time, but there were no consistent time changes for FPA or Sm. Serum insulin concentration was higher (P less than .05) in implanted lambs than in controls (33.4 vs 25.6 microU/ml). Unlike insulin, serum Sm and FPA were not affected by zeranol implantation, and, thus, these serum factors appeared not to be involved in zeranol-stimulated growth. Sm was higher in the faster growing Sx lambs than in the slower growing Fx lambs. Thus, serum Sm activity may be involved in normal regulation of growth.
D000818:Animals; D004343:Drug Implants; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D007328:Insulin / Q000097:blood*; D008297:Male; D012118:Resorcinols / Q000494:pharmacology*; D012756:Sheep / Q000378:metabolism*; D013002:Somatomedins / Q000097:blood*; D013045:Species Specificity; D015029:Zeranol / Q000494:pharmacology*
D004343:Drug Implants; D007328:Insulin; D012118:Resorcinols; D013002:Somatomedins; D015029:Zeranol